Loading clinical trials...
Loading clinical trials...
Schizophrenia is a major psychotic disorder that presents an enormous burden to the patients and their relatives. Despite treatment with second generation antipsychotics, negative symptoms and cogniti...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH
Collaborators
NCT07565428 · Negative Symptoms of Schizophrenia
NCT07645443 · Early Onset Psychosis, First Psychotic Episode Within the Last 5 Years, and more
NCT06257056 · Treatment-Refractory Schizophrenia
NCT07288333 · Schizophrenia
NCT07105098 · Schizophrenia
Department of Psychiatry and Psychotherapy, University of Regensburg
Regensburg, Bavaria
Dept. of Psychiatry and Psychotherapy, University Hospital of the Georg-August-University Göttingen
Göttingen, Lower Saxony
Department of Psychiatry, Heinrich-Heine University Hospital
Düsseldorf, North Rhine-Westphalia
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions